Leptin: Clinical Trials

19 trials of Leptin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 2 terminated, 2 unknown. 7 Phase 2, 5 Not applicable, 3 Phase 1, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Not applicable5Completed 3, Terminated 1, Unknown 1
Phase 13Completed 2, Terminated 1
Phase 32Completed 1, Unknown 1
Phase 41Completed 1

Follow Leptin: new trials by email Literature Review of Leptin trials Research Report on Leptin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-control Study.
Leptin - Oral Lichen Planus, Leptin Levels
CompletedCairo University782023-12-302025-03-30
Nutrition and Growth in Very Preterm Infants
Oral nutritional intake - Premature, Growth
CompletedChildren's Hospital of Fudan University1802019-08-012023-02-08
Serotonin, Leptin and Adiponectin Level in Patients With Postpartum Depression: Controlled Study
leptin, serotonin and adiponectin level, leptin,serotonin, adiponectin level - Postpartum Depression
CompletedZeynep Kamil Maternity and Pediatric Research and Training Hospital4002016-02-012022-03-15
Hypercortisolism and Epicardial Adipose Tissue
Blood samples for measuring adiponectin, leptin and omentin plasma, MRI at 3 Tesla - Hypercortisolism
Not applicableCompletedAssistance Publique Hopitaux De Marseille432014-12-082023-05-26
Mother-caregivers of Children With Duchenne Muscular Dystrophy
sleep parameters, Hormonal profile, Inflammatory profile - Other Diseases or Conditions
Not applicableCompletedMonica Levy Andersen602013-08-012016-02-03
Effects of Metreleptin in Type 1 Diabetes Mellitus
Leptin - Type 1 Diabetes
Phase 1TerminatedUniversity of Texas Southwestern Medical Center82010-09-012019-08-28
Leptin in the Maintenance of Reduced Body Weight
Leptin, Placebo - Obesity
Phase 2CompletedBeth Israel Deaconess Medical Center242008-07-012017-04-07
Trial of Leptin Administration After Roux-en-Y Gastric Bypass
Leptin, Placebo - Overweight
Phase 1 / Phase 2CompletedColumbia University312008-04-012015-11-16
Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
Leptin, Pioglitazone or metformin, Placebo - HIV Lipodystrophy
Phase 2CompletedBeth Israel Deaconess Medical Center92006-08-012017-03-23
Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Leptin, Placebo - Hypoleptinemia, Generalized Lipodystrophy
Phase 2 / Phase 3CompletedUniversity of Texas Southwestern Medical Center252006-04-012024-03-27
A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide
Pramlintide (Amylin), Placebo (Normal Saline), 2 Metreleptin - Obesity
Not applicableUnknownOregon Health and Science University102006-01-012022-12-16
Leptin and Endothelial Function
leptin - Healthy
Phase 4CompletedUniversity of Michigan152004-09-012006-06-27
Therapeutic Approaches to HAART-Induced Lipodystrophy
Leptin, Placebo - HIV Infections, Lipodystrophy
Phase 2CompletedUniversity of Texas Southwestern Medical Center232003-01-012019-05-09
Leptin in Human Energy and Neuroendocrine Homeostasis
Subcutaneous Placebo, Leptin - Obesity, Weight Loss
Not applicableTerminatedColumbia University222002-07-012019-09-18
In Vivo Leptin Signaling in Humans After Acute Leptin Administration
leptin - Lean, Obese
Phase 1CompletedBeth Israel Deaconess Medical Center122002-07-012017-10-17
Leptin to Treat Lipodystrophy
Metreleptin - Lipodystrophy
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1032001-10-012016-08-16
Effects of Leptin Treatment on Weight Loss
Leptin, Very Low Calorie Diet - Obesity
Phase 2CompletedRockefeller University402001-03-012010-10-19
Low-Dose Leptin and the Formerly-Obese
Leptin, Dietary modification, T3 repletion - Obesity
Phase 3UnknownNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)252000-07-012015-06-04
Recombinant Human Leptin Therapy Effects on Insulin Action
placebo, low-dose leptin, high-dose leptin - Type Two Diabetes Mellitus
Not applicableCompletedWashington University School of Medicine181998-08-012015-07-09

Conditions studied

Obesity (7)  ·  Lipodystrophy (3)  ·  Diabetes Mellitus (2)  ·  Insulin Resistance (2)  ·  Overweight (2)  ·  Weight Loss (2)  ·  Cushing Syndrome (1)  ·  Depression, Postpartum (1)  ·  Diabetes Mellitus, Lipoatrophic (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  HIV Infections (1)  ·  HIV-Associated Lipodystrophy Syndrome (1)  ·  Hypertriglyceridemia (1)  ·  Lichen Planus, Oral (1)  ·  Lipodystrophy, Congenital Generalized (1)

Sponsors

Beth Israel Deaconess Medical Center (3)  ·  University of Texas Southwestern Medical Center (3)  ·  Columbia University (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Cairo University (1)  ·  Children's Hospital of Fudan University (1)  ·  Monica Levy Andersen (1)  ·  Oregon Health and Science University (1)  ·  Rockefeller University (1)  ·  University of Michigan (1)  ·  Washington University School of Medicine (1)  ·  Zeynep Kamil Maternity and Pediatric Research and Training Hospital (1)

Countries

United States (13)  ·  Brazil (1)  ·  China (1)  ·  Egypt (1)  ·  France (1)  ·  Turkey (Türkiye) (1)

Top investigators

Abhimanyu Garg, M.D. (2)  ·  Abhimanyu Garg, MD (1)  ·  Christos Mantzoros, MD (1)  ·  Christos S Mantzoros, MD (1)  ·  Jeffrey Friedman, MD, PHD (1)  ·  Jonathan Q. Purnell, M.D. (1)  ·  Judith Korner, MD,PhD (1)  ·  Michael Rosenbaum, MD (1)  ·  Olfat Ga Shaker, PHD (1)  ·  Phillip Gorden, M.D. (1)  ·  Weam Ah Rashwan, PHD (1)  ·  Weili Yan, MD, PhD (1)

Results publications

PMID 19427131, PMID 19727665, PMID 21411512, PMID 22068254, PMID 22965160, PMID 23382191, PMID 24926953, PMID 25070319, PMID 25469244, PMID 25734254, PMID 26589105, PMID 26748249, PMID 26900642, PMID 28324110, PMID 29920214, PMID 31194872, PMID 34223895, PMID 34677608, PMID 37595266

NIH funding

R01DK064773 (1), R01DK079929 (1), R21DK081050 (1), UL1RR024156 (1)